Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802109

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1802109

Global Peritoneal Dialysis Market Size study & Forecast, by Product Type (CAPD and APD), Product (Cyclers and Fluids), End User (Home healthcare and Hospitals) and Regional Forecasts 2025-2035

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

The Global Peritoneal Dialysis Market is valued at approximately USD 5.62 billion in 2024 and is anticipated to grow at a CAGR of 9.60% over the forecast period 2025-2035. Peritoneal dialysis (PD) is a life-sustaining renal replacement therapy that leverages the body's peritoneum as a natural semipermeable membrane to filter waste products and excess fluid when kidneys fail to function properly. Unlike traditional hemodialysis, PD can be performed at home, allowing patients greater independence and flexibility. Its growing adoption is being driven by rising prevalence of end-stage renal disease (ESRD), surging incidence of diabetes and hypertension, and the increasing preference for home-based care. Technological advancements in PD solutions, improved cycler devices, and the support of government reimbursement policies are expected to further stimulate market expansion throughout the forecast horizon.

The escalating global burden of chronic kidney disease has fueled an undeniable surge in the demand for peritoneal dialysis. According to the International Society of Nephrology, more than 850 million people worldwide are living with kidney disease, a significant proportion of whom will require dialysis during their lifetime. Patients are progressively shifting toward PD owing to its lower infrastructure needs, cost-effectiveness, and greater patient-centric benefits compared to in-center hemodialysis. Moreover, innovations in PD fluids designed to reduce complications, along with integration of smart digital health platforms for remote monitoring, are unlocking lucrative opportunities for healthcare providers and device manufacturers alike. However, the market's growth trajectory could be hampered by risks of peritonitis, concerns around patient adherence, and competition from hemodialysis and kidney transplantation.

The detailed segments and sub-segments included in the report are:

By Product Type:

  • CAPD (Continuous Ambulatory Peritoneal Dialysis)
  • APD (Automated Peritoneal Dialysis)

By Product:

  • Cyclers
  • Fluids

By End User:

  • Home Healthcare
  • Hospitals

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
  • Continuous Ambulatory Peritoneal Dialysis (CAPD) is expected to dominate the market. CAPD's leadership is attributed to its simplicity, cost-effectiveness, and the flexibility it affords patients who wish to administer treatment without machines or clinical assistance. This method has been particularly well received in developing economies where access to hospital-based dialysis centers is limited, thereby cementing its role as the most widely adopted form of PD. Furthermore, patient preference for a portable, low-technology solution that seamlessly integrates into daily life continues to fuel CAPD's strong market share. While APD is increasingly popular in developed countries due to its automated convenience during nighttime hours, CAPD remains the cornerstone of PD adoption globally.
  • On the revenue side, PD fluids contribute the lion's share to the market, driven by their recurring and indispensable nature in every dialysis cycle. As PD therapy requires daily use of dialysate solutions, this segment inherently sustains consistent demand and thus dominates revenue streams. Although cyclers are witnessing rapid technological innovation and uptake, particularly in APD, they represent a one-time or infrequent capital purchase. In contrast, the continuous consumption of fluids creates an enduring revenue pipeline for manufacturers, making it the leading contributor to the industry's topline performance.
  • The key regions considered for the Global Peritoneal Dialysis Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America currently commands the largest market share, driven by advanced healthcare infrastructure, supportive reimbursement frameworks, and high prevalence of ESRD among the aging population. Europe follows closely, supported by strong public healthcare systems and favorable policies encouraging home dialysis adoption. However, Asia Pacific is anticipated to be the fastest-growing region, spurred by surging patient volumes in densely populated countries like China and India, increasing investments in healthcare infrastructure, and rising awareness about cost-effective dialysis modalities. Latin America and the Middle East & Africa are gradually emerging with untapped opportunities, as government initiatives and private investments accelerate dialysis accessibility.

Major market players included in this report are:

  • Baxter International Inc.
  • Fresenius Medical Care AG & Co. KGaA
  • B. Braun Melsungen AG
  • Medtronic plc
  • Nipro Corporation
  • DaVita Inc.
  • Toray Medical Co., Ltd.
  • Terumo Corporation
  • Cantel Medical Corp.
  • JMS Co. Ltd.
  • AWAK Technologies
  • Dialife SA
  • Medionics Healthcare Pvt. Ltd.
  • Renax Biomedical Tech. Co., Ltd.
  • Asahi Kasei Medical Co., Ltd.

Global Peritoneal Dialysis Market Report Scope:

  • Historical Data - 2023, 2024
  • Base Year for Estimation - 2024
  • Forecast period - 2025-2035
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2025 to 2035.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of the geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of the competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Peritoneal Dialysis Market Report Scope & Methodology

  • 1.1. Research Objective
  • 1.2. Research Methodology
    • 1.2.1. Forecast Model
    • 1.2.2. Desk Research
    • 1.2.3. Top Down and Bottom-Up Approach
  • 1.3. Research Attributes
  • 1.4. Scope of the Study
    • 1.4.1. Market Definition
    • 1.4.2. Market Segmentation
  • 1.5. Research Assumption
    • 1.5.1. Inclusion & Exclusion
    • 1.5.2. Limitations
    • 1.5.3. Years Considered for the Study

Chapter 2. Executive Summary

  • 2.1. CEO/CXO Standpoint
  • 2.2. Strategic Insights
  • 2.3. ESG Analysis
  • 2.4. key Findings

Chapter 3. Global Peritoneal Dialysis Market Forces Analysis

  • 3.1. Market Forces Shaping The Global Peritoneal Dialysis Market (2024-2035)
  • 3.2. Drivers
    • 3.2.1. Rising prevalence of end-stage renal disease (ESRD)
    • 3.2.2. Increasing preference for home-based care
  • 3.3. Restraints
    • 3.3.1. Risks of peritonitis
    • 3.3.2. Concerns around patient adherence
  • 3.4. Opportunities
    • 3.4.1. Technological advancements in PD solutions
    • 3.4.2. Integration of smart digital health platforms for remote monitoring

Chapter 4. Global Spacer Fluid Industry Analysis

  • 4.1. Porter's 5 Forces Model
    • 4.1.1. Bargaining Power of Buyer
    • 4.1.2. Bargaining Power of Supplier
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Forecast Model (2024-2035)
  • 4.3. PESTEL Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top Investment Opportunities
  • 4.5. Top Winning Strategies (2025)
  • 4.6. Market Share Analysis (2024-2025)
  • 4.7. Global Pricing Analysis And Trends 2025
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Peritoneal Dialysis Market Size & Forecasts by Product Type 2025-2035

  • 5.1. Market Overview
  • 5.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
  • 5.3. CAPD (Continuous Ambulatory Peritoneal Dialysis)
    • 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.3.2. Market size analysis, by region, 2025-2035
  • 5.4. APD (Automated Peritoneal Dialysis)
    • 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 5.4.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Peritoneal Dialysis Market Size & Forecasts by Product 2025-2035

  • 6.1. Market Overview
  • 6.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
  • 6.3. Cyclers
    • 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.3.2. Market size analysis, by region, 2025-2035
  • 6.4. Fluids
    • 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 6.4.2. Market size analysis, by region, 2025-2035

Chapter 7. Global Peritoneal Dialysis Market Size & Forecasts by End User 2025-2035

  • 7.1. Market Overview
  • 7.2. Global Growth Hormone Deficiency Market Performance - Potential Analysis (2025)
  • 7.3. Home Healthcare
    • 7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 7.3.2. Market size analysis, by region, 2025-2035
  • 7.4. Hospitals
    • 7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
    • 7.4.2. Market size analysis, by region, 2025-2035

Chapter 8. Global Peritoneal Dialysis Market Size & Forecasts by Region 2025-2035

  • 8.1. Growth Peritoneal Dialysis Market, Regional Market Snapshot
  • 8.2. Top Leading & Emerging Countries
  • 8.3. North America Peritoneal Dialysis Market
    • 8.3.1. U.S. Peritoneal Dialysis Market
      • 8.3.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.3.1.2. Product breakdown size & forecasts, 2025-2035
      • 8.3.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.3.2. Canada Peritoneal Dialysis Market
      • 8.3.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.3.2.2. Product breakdown size & forecasts, 2025-2035
      • 8.3.2.3. End User breakdown size & forecasts, 2025-2035
  • 8.4. Europe Peritoneal Dialysis Market
    • 8.4.1. UK Peritoneal Dialysis Market
      • 8.4.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.4.1.2. Product breakdown size & forecasts, 2025-2035
      • 8.4.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.2. Germany Peritoneal Dialysis Market
      • 8.4.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.4.2.2. Product breakdown size & forecasts, 2025-2035
      • 8.4.2.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.3. France Peritoneal Dialysis Market
      • 8.4.3.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.4.3.2. Product breakdown size & forecasts, 2025-2035
      • 8.4.3.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.4. Spain Peritoneal Dialysis Market
      • 8.4.4.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.4.4.2. Product breakdown size & forecasts, 2025-2035
      • 8.4.4.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.5. Italy Peritoneal Dialysis Market
      • 8.4.5.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.4.5.2. Product breakdown size & forecasts, 2025-2035
      • 8.4.5.3. End User breakdown size & forecasts, 2025-2035
    • 8.4.6. Rest of Europe Peritoneal Dialysis Market
      • 8.4.6.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.4.6.2. Product breakdown size & forecasts, 2025-2035
      • 8.4.6.3. End User breakdown size & forecasts, 2025-2035
  • 8.5. Asia Pacific Peritoneal Dialysis Market
    • 8.5.1. China Peritoneal Dialysis Market
      • 8.5.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.5.1.2. Product breakdown size & forecasts, 2025-2035
      • 8.5.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.2. India Peritoneal Dialysis Market
      • 8.5.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.5.2.2. Product breakdown size & forecasts, 2025-2035
      • 8.5.2.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.3. Japan Peritoneal Dialysis Market
      • 8.5.3.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.5.3.2. Product breakdown size & forecasts, 2025-2035
      • 8.5.3.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.4. Australia Peritoneal Dialysis Market
      • 8.5.4.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.5.4.2. Product breakdown size & forecasts, 2025-2035
      • 8.5.4.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.5. South Korea Peritoneal Dialysis Market
      • 8.5.5.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.5.5.2. Product breakdown size & forecasts, 2025-2035
      • 8.5.5.3. End User breakdown size & forecasts, 2025-2035
    • 8.5.6. Rest of APAC Peritoneal Dialysis Market
      • 8.5.6.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.5.6.2. Product breakdown size & forecasts, 2025-2035
      • 8.5.6.3. End User breakdown size & forecasts, 2025-2035
  • 8.6. Latin America Peritoneal Dialysis Market
    • 8.6.1. Brazil Peritoneal Dialysis Market
      • 8.6.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.6.1.2. Product breakdown size & forecasts, 2025-2035
      • 8.6.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.6.2. Mexico Peritoneal Dialysis Market
      • 8.6.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.6.2.2. Product breakdown size & forecasts, 2025-2035
      • 8.6.2.3. End User breakdown size & forecasts, 2025-2035
  • 8.7. Middle East and Africa Peritoneal Dialysis Market
    • 8.7.1. UAE Peritoneal Dialysis Market
      • 8.7.1.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.7.1.2. Product breakdown size & forecasts, 2025-2035
      • 8.7.1.3. End User breakdown size & forecasts, 2025-2035
    • 8.7.2. Saudi Arabia (KSA) Peritoneal Dialysis Market
      • 8.7.2.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.7.2.2. Product breakdown size & forecasts, 2025-2035
      • 8.7.2.3. End User breakdown size & forecasts, 2025-2035
    • 8.7.3. South Africa Peritoneal Dialysis Market
      • 8.7.3.1. Product Type breakdown size & forecasts, 2025-2035
      • 8.7.3.2. Product breakdown size & forecasts, 2025-2035
      • 8.7.3.3. End User breakdown size & forecasts, 2025-2035

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Baxter International Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Financial Performance (Subject to Data Availability)
    • 9.2.5. Product/Services Port
    • 9.2.6. Recent Development
    • 9.2.7. Market Strategies
    • 9.2.8. SWOT Analysis
  • 9.3. Fresenius Medical Care AG & Co. KGaA
  • 9.4. B. Braun Melsungen AG
  • 9.5. Medtronic plc
  • 9.6. Nipro Corporation
  • 9.7. DaVita Inc.
  • 9.8. Toray Medical Co., Ltd.
  • 9.9. Terumo Corporation
  • 9.10. Cantel Medical Corp.
  • 9.11. JMS Co. Ltd.
  • 9.12. AWAK Technologies
  • 9.13. Dialife SA
  • 9.14. Medionics Healthcare Pvt. Ltd.
  • 9.15. Renax Biomedical Tech. Co., Ltd.
  • 9.16. Asahi Kasei Medical Co., Ltd.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!